How psilocybin may reshape brain connections to help with stress-related problems
Synaptic circuit mechanisms underlying psilocybin's therapeutic effects in the stressed brain
Researchers are looking at whether psilocybin can repair stress-damaged brain connections to help people with stress-related mood and anxiety problems.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Santa Cruz NIH-funded |
| Lab location | 1 site (Santa Cruz, United States) |
| Project ID | NIH-11196774 on NIH RePORTER |
What this research studies
This project uses stressed animal models to see how a dose of psilocybin changes nerve-cell connections over time. Scientists will watch individual synapses with high-resolution two-photon imaging, track which new connections persist, and link those changes to behavior. The team will test whether lasting incorporation of new synapses into brain circuits explains durable improvements after psilocybin. Findings aim to connect cellular changes to recovery from stress-related deficits.
Who could benefit from this research
Good fit: People with stress-linked depression, anxiety, or PTSD—especially those whose symptoms have not improved with standard treatments—are the patients most likely to benefit from this line of research.
Not a fit: Patients seeking immediate clinical treatment or those with conditions unrelated to stress-driven circuit changes (for example purely developmental disorders) should not expect direct benefit from this basic laboratory research.
Why it matters
Potential benefit: If successful, this work could reveal how psilocybin produces lasting relief from stress-related symptoms and guide safer, more targeted treatments for conditions like depression or PTSD.
How similar studies have performed: Prior animal studies and early human trials show psychedelics can rapidly increase neural plasticity and improve mood, but the precise synaptic circuit mechanisms remain largely untested and are the focus here.
Where this research is happening
Santa Cruz, United States
- University of California Santa Cruz — Santa Cruz, United States (Active)
Researchers
- Principal investigator: Zuo, Yi — University of California Santa Cruz
- Study coordinator: Zuo, Yi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.